from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2576c/-

LFCtreatmentdescriptionclass of inhibitor

-0.944

Amikacinug/mL Amikacintranslation

-1.132

Cap5-10ug/mL Capreomycintranslation

-1.537

Rox10-50 ug/mL Roxithromycintranslation

-0.199

SM2-5 ug/mL Streptomycintranslation

-0.554

Tet5-10 ug/mL Tetracyclinetranslation

-1.759

Rif0.2-5ug/mL Rifampicintranscription

-1.805

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.180

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.092

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.845

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.469

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.161

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.555

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.486

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.630

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.072

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.094

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.046

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.383

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.252

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.635

KCN5-20 ug/mL Potassium cyaniderespiration

1.219

NaN30.2-2 mM Sodium aziderespiration

-0.459

Nigericin50 uM Nigericinrespiration

0.469

TRC10-150 ug/mL Triclosanrespiration

-0.771

TRZ10-25 ug/mL Thioridazinerespiration

-0.661

Valinomycin0.5-10 uM Valinomycinrespiration

0.121

ZnSO42 mM ZnSO4respiration

0.318

menadione6-10 ug/mL Menadionerespiration

-0.281

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.029

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.316

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.285

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.219

NRP_1Non-replicating persistence stage 1dosRassociated

0.046

Amp0.2mg/mL AmpicillincellWall

0.045

Cephalexin20-100 ug/mL CephalexincellWall

-0.164

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.259

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.393

EMB10-20 ug/mL EthambutolcellWall

0.274

Eta12-40 ug/mL EthionamidecellWall

0.703

INH0.2-0.4 ug/mL IsoniazidcellWall

0.432

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.626

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.370

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.323

BZA0.12 mg/mL BenzamidearomaticAmides

1.021

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.081

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.269

H2O24 mM hydrogen peroxideDNAdamaging

-0.160

Levo10 ug/mL LevofloxacinDNAdamaging

-0.006

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.696

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.204

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.570

UVUV-irradiationDNAdamaging

-1.194

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.490

Antimycin12.5-50 ug/mL Antimycin A?

-0.360

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.191

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.280

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.497

PA8240.2-2 ug/mL PA-824?

1.489

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.417

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.392

Verapamil50 uM Verapamil?

0.097

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.579

methoxatin10-20 ug/mL Methoxatin?